- Company List - N
- NMTC
Insider Trading activities at Neuroone Medical Technologies Corp (NMTC)
Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Neuroone Medical Technologies Corp (NMTC)
since 2017 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Neuroone Medical Technologies Corp.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1500198.
Total stock buying since 2017: $355,758.
Total stock sales since 2017: $685,253.
Total stock option exercises since 2017: $1,190.
Table 1. Yearly summary of insider stock purchases, sales, and option exercises
at Neuroone Medical Technologies Corp (NMTC).
|
Insider Buying |
Insider Sales |
Option Exercises |
| Year |
Shares | Value |
Shares | Value |
Shares | Value |
| 2025 | 300,000 | $150,000 | 30,000 | $18,702 | 0 | $0 |
| 2024 | 0 | $0 | 27,989 | $24,569 | 0 | $0 |
| 2023 | 125,900 | $155,034 | 76,500 | $111,608 | 0 | $0 |
| 2022 | 52,000 | $50,221 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 11,900 | $79,975 | 0 | $0 |
| 2020 | 0 | $0 | 334,000 | $200,400 | 34,020 | $1,190 |
| 2018 | 0 | $0 | 227,272 | $249,999 | 0 | $0 |
| 2017 | 15,728 | $503 | 0 | $0 | 0 | $0 |
Table 2. Monthly summary of insider trading at Neuroone Medical Technologies Corp (NMTC).
| Trading Period |
Insider Buying |
Insider Sales |
Option Exercises |
| year-month |
Shares | Value |
Shares | Value |
Shares | Value |
| 2025-06 | 0 | $0 | 10,000 | $5,800 | 0 | $0 |
| 2025-05 | 0 | $0 | 20,000 | $12,902 | 0 | $0 |
| 2025-04 | 300,000 | $150,000 | 0 | $0 | 0 | $0 |
| 2024-06 | 0 | $0 | 27,989 | $24,569 | 0 | $0 |
| 2023-12 | 75,000 | $105,000 | 50,000 | $71,507 | 0 | $0 |
| 2023-09 | 50,900 | $50,034 | 0 | $0 | 0 | $0 |
| 2023-03 | 0 | $0 | 26,500 | $40,101 | 0 | $0 |
| 2022-06 | 24,000 | $25,004 | 0 | $0 | 0 | $0 |
| 2022-05 | 28,000 | $25,217 | 0 | $0 | 0 | $0 |
| 2021-06 | 0 | $0 | 11,900 | $79,975 | 0 | $0 |
| 2020-06 | 0 | $0 | 334,000 | $200,400 | 34,020 | $1,190 |
| 2018-03 | 0 | $0 | 227,272 | $249,999 | 0 | $0 |
| 2017-05 | 15,728 | $503 | 0 | $0 | 0 | $0 |
Table 3. Detailed insider trading at Neuroone Medical Technologies Corp (NMTC)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-06-04 | Christianson Mark (Business Development Director) | Sale | 10,000 | .58 | 5,800 |
| 2025-05-22 | Christianson Mark (Business Development Director) | Sale | 8,967 | .62 | 5,586 |
| 2025-05-21 | Christianson Mark (Business Development Director) | Sale | 14 | .65 | 9 |
| 2025-05-20 | Christianson Mark (Business Development Director) | Sale | 3,013 | .66 | 1,976 |
| 2025-05-19 | Christianson Mark (Business Development Director) | Sale | 8,006 | .67 | 5,331 |
| 2025-04-04 | Mcclurg Ronald W. (Chief Financial Officer) | Buy | 200,000 | .50 | 100,000 |
| 2025-04-04 | Rosa David A (CEO and President) | Buy | 100,000 | .50 | 50,000 |
| 2024-06-06 | Christianson Mark (Business Development Director) | Sale | 2,189 | .88 | 1,917 |
| 2024-06-05 | Christianson Mark (Business Development Director) | Sale | 25,800 | .88 | 22,652 |
| 2023-12-27 | Christianson Mark (Business Development Director) | Sale | 31,445 | 1.46 | 45,846 |
| 2023-12-26 | Christianson Mark (Business Development Director) | Sale | 6,848 | 1.35 | 9,272 |
| 2023-12-22 | Christianson Mark (Business Development Director) | Sale | 1,800 | 1.40 | 2,520 |
| 2023-12-21 | Volker Christopher (Chief Operating Officer) | Buy | 75,000 | 1.40 | 105,000 |
| 2023-12-21 | Christianson Mark (Business Development Director) | Sale | 9,907 | 1.40 | 13,869 |
| 2023-09-13 | Mcclurg Ronald W. (Chief Financial Officer) | Buy | 50,900 | .98 | 50,034 |
| 2023-03-23 | Christianson Mark (Business Development Director) | Sale | 12,711 | 1.50 | 19,091 |
| 2023-03-22 | Christianson Mark (Business Development Director) | Sale | 11,667 | 1.51 | 17,605 |
| 2023-03-21 | Christianson Mark (Business Development Director) | Sale | 2,122 | 1.60 | 3,405 |
| 2022-06-15 | Mcclurg Ronald W. (Chief Financial Officer) | Buy | 10,000 | 1.02 | 10,220 |
| 2022-06-10 | Mcclurg Ronald W. (Chief Financial Officer) | Buy | 14,000 | 1.06 | 14,784 |
| 2022-05-24 | Mcclurg Ronald W. (Chief Financial Officer) | Buy | 10,500 | .98 | 10,290 |
| 2022-05-20 | Mcclurg Ronald W. (Chief Financial Officer) | Buy | 17,500 | .85 | 14,927 |
| 2021-06-24 | Christianson Mark (Business Development Director) | Sale | 600 | 6.30 | 3,780 |
| 2021-06-23 | Christianson Mark (Business Development Director) | Sale | 11,300 | 6.74 | 76,195 |
| 2020-06-15 | Mathiesen Jeffrey S (Director) | Option Ex | 34,020 | .04 | 1,190 |
| 2020-06-12 | Christianson Mark (VP of Market Development) | Sale | 334,000 | .60 | 200,400 |
| 2018-03-01 | Fredrickson Wade | Sale | 227,272 | 1.10 | 249,999 |
| 2017-05-19 | Samad Amer (Chief Executive Officer) | Buy | 15,728 | .03 | 503 |
Insider trading activities including stock purchases, stock sales, and option exercises
of NMTC listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Neuroone Medical Technologies Corp (symbol NMTC,
CIK number 1500198) see
the Securities and Exchange Commission (SEC) website.